Boston Partners Bausch Health Companies Inc. Transaction History

Boston Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$21.6 - $27.79 $1.33 Million - $1.71 Million	-61,447 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$25.04 - $30.06 $221,654 - $266,091	-8,852 Reduced 12.59%	61,447 $1.71 Million
Q2 2021 Aug 12, 2021	SELL	$27.43 - $32.7 $41,117 - $49,017	-1,499 Reduced 2.09%	70,299 $2.06 Million
Q1 2021 May 10, 2021	SELL	$21.37 - $34.38 $1.13 Million - $1.82 Million	-52,906 Reduced 42.43%	71,798 $2.28 Million
Q4 2020 Feb 04, 2021	SELL	$15.31 - $21.12 $168,700 - $232,721	-11,019 Reduced 8.12%	124,704 $2.59 Million
Q3 2020 Nov 13, 2020	SELL	$14.88 - $20.13 $62,004 - $83,881	-4,167 Reduced 2.98%	135,723 $2.11 Million
Q2 2020 Aug 12, 2020	SELL	$13.31 - $20.51 $1.12 Million - $1.73 Million	-84,275 Reduced 37.6%	139,890 $2.56 Million
Q1 2020 May 13, 2020	BUY	$12.98 - $30.25 $2.91 Million - $6.78 Million	224,165 New	224,165 $3.48 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.